Nathan Caffo

Corporate Officer/Principal chez CANDEL THERAPEUTICS, INC.

55 ans

Health Technology

Consumer Services

Postes actifs de Nathan Caffo

Sociétés	Poste	Début	Fin
CANDEL THERAPEUTICS, INC.	Corporate Officer/Principal	01/09/2020	-

Sociétés	Poste	Début	Fin
ALX ONCOLOGY HOLDINGS INC.	Corporate Officer/Principal	01/09/2018	01/09/2020
Presage Biosciences, Inc. Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA.	Directeur Général	01/04/2009	17/07/2018
	President	01/04/2009	01/08/2018

The Pennsylvania State University

Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Corporate Officer/Principal	2
Chief Executive Officer	1
President	1

Sectorielle

Health Technology	4
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
ALX ONCOLOGY HOLDINGS INC.	Health Technology
CANDEL THERAPEUTICS, INC.	Health Technology

Entreprise privées	1
Presage Biosciences, Inc. Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA.	Health Technology

Entreprise privées

Health Technology